a Parallel, Randomised, Open-Label Clinical Trial Evaluating the Safety and Efficacy of Methotrexate With Apremilast in Patients With Moderate to Severe Palmoplantar Psoriasis. Int. J. Pharm. Sci. Lett. 2020, 10 (1), 29-39.